Carmell (CTCX) Competitors $2.84 +0.01 (+0.35%) As of 08/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. RXST, OM, SNWV, STIM, CLPT, CATX, NPCE, NNOX, NYXH, and DRTSShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include RxSight (RXST), Outset Medical (OM), Sanuwave Health (SNWV), Neuronetics (STIM), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), NeuroPace (NPCE), Nano-X Imaging (NNOX), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors RxSight Outset Medical Sanuwave Health Neuronetics ClearPoint Neuro Perspective Therapeutics NeuroPace Nano-X Imaging Nyxoah Alpha Tau Medical RxSight (NASDAQ:RXST) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Do analysts rate RXST or CTCX? RxSight presently has a consensus target price of $12.22, indicating a potential upside of 59.77%. Given RxSight's stronger consensus rating and higher probable upside, equities analysts plainly believe RxSight is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 2 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.91Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation & earnings, RXST or CTCX? Carmell has lower revenue, but higher earnings than RxSight. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$139.93M2.22-$27.45M-$0.67-11.42Carmell$32.84K1,807.92-$15.44MN/AN/A Is RXST or CTCX more profitable? Carmell has a net margin of 0.00% compared to RxSight's net margin of -17.90%. RxSight's return on equity of -9.54% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-17.90% -9.54% -8.51% Carmell N/A -217.50%-50.22% Do institutionals and insiders have more ownership in RXST or CTCX? 78.8% of RxSight shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 9.6% of RxSight shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to RXST or CTCX? In the previous week, RxSight had 39 more articles in the media than Carmell. MarketBeat recorded 39 mentions for RxSight and 0 mentions for Carmell. RxSight's average media sentiment score of 0.11 beat Carmell's score of 0.00 indicating that RxSight is being referred to more favorably in the media. Company Overall Sentiment RxSight Neutral Carmell Neutral Which has more risk & volatility, RXST or CTCX? RxSight has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. SummaryRxSight beats Carmell on 10 of the 14 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.37M$64.36M$5.59B$9.53BDividend YieldN/AN/A4.71%4.14%P/E RatioN/A6.2028.8923.88Price / Sales1,807.92103.72447.6498.82Price / CashN/A18.4135.6858.35Price / Book2.656.688.165.60Net Income-$15.44M-$25.81M$3.25B$265.26M7 Day Performance-27.37%-4.40%1.12%-0.15%1 Month Performance16.39%0.31%8.22%6.07%1 Year Performance158.18%44.06%29.12%24.21% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$2.84+0.4%N/A+153.6%$59.37M$32.84K0.0014RXSTRxSight3.2937 of 5 stars$7.83-0.5%$17.50+123.5%-81.2%$318.19M$148.31M-11.69220Trending NewsUpcoming EarningsOMOutset Medical1.744 of 5 stars$17.54-2.8%$29.50+68.2%-73.1%$310.84M$115.27M-0.60520News CoveragePositive NewsSNWVSanuwave Health2.2728 of 5 stars$34.76-2.8%$49.00+41.0%N/A$297.89M$32.63M-7.6340Gap UpSTIMNeuronetics1.1903 of 5 stars$4.47-1.1%$5.50+23.0%+155.6%$295.51M$74.89M-3.41180News CoverageGap DownCLPTClearPoint Neuro2.8195 of 5 stars$10.55-3.8%$25.00+137.0%+62.5%$295.28M$32.24M-13.88110Upcoming EarningsCATXPerspective Therapeutics2.5857 of 5 stars$3.92-4.9%$12.56+220.3%-67.2%$290.97MN/A0.0070Upcoming EarningsNPCENeuroPace3.245 of 5 stars$8.78+0.5%$17.00+93.6%+25.0%$287.98M$84.31M-10.45170News CoverageUpcoming EarningsNNOXNano-X Imaging1.9611 of 5 stars$4.89-4.9%$9.50+94.3%-32.4%$282.54M$11.55M-5.43190News CoverageUpcoming EarningsGap UpNYXHNyxoah2.9601 of 5 stars$7.48+4.3%$14.50+93.9%-6.4%$254.77M$4.36M-3.51110Gap UpDRTSAlpha Tau Medical2.4165 of 5 stars$2.90-3.3%$8.00+175.9%+51.2%$245.98MN/A-6.3080News CoveragePositive NewsUpcoming Earnings Related Companies and Tools Related Companies RXST Alternatives OM Alternatives SNWV Alternatives STIM Alternatives CLPT Alternatives CATX Alternatives NPCE Alternatives NNOX Alternatives NYXH Alternatives DRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCX Stock Alerts